Antibiotic Agents Targeting Bacterial Cell Wall Synthesis Flashcards
Clavulanic acid, tazobactam, and avibactam are all
b-lactamase inhibitors
Cefazolin (1stgen), cefuroxime axetil (2ndgen), ceftazidime (3rdgen), cefepime (4thgen), and ceftolozane (the latest) are all?
Cephalosporins
Ceftaroline is a
Cephalosporin for MRSA
Aztreonam is a
Monobactam
Imipenem is a
Carbapenem
Vancomycin, oritavancin, and dalbavancin are classified as
Glycopeptides
Daptomycin (pore former) and polymyxins (membrane disruptors) are examples of
Lipopeptides
Fosfomycin, bacitracin, and D-cycloserine are inhibitors of
Peptidoglycan precursors
Life-threatening infections require the immediate use of broad-spectrum agents or
Combination therapy
A microorganism is said to be resistant to a drug if therapeutic levels of the drug at a particular site cannot be
Safely or effectively achieved
Exposure to harmful agents such as antibiotics increases the selective pressure to maintain
Acquired resistance
Many drugs work selectively against Gram(+) bacteria. Fewer work selectively against Gram(-) bacteria. Drugs that work against both classes of bacteria are said to be
Broad spectrum
A drug whose selectivity is broadened by chemical modification is said to have an
Extended spectrum
The outer membrane of Gram(-) bacteria is relatively
Impermeable
Cell wall agents block proper assembly of the
Peptidoglycan layer
Join the sugars that make polysaccharide chains
Transglycolase enzymes
Join the sugar-linked peptides to x-link polysaccharide chains
Transpeptidase enzymes
Mimics D-Ala-D-Ala, the last two amino acids of the peptide-bridge precursor
Penicillin
Similar to transpeptidases. However, they use H2O to hydrolyze serine-lactam linkage
Serine B-lactamases
A distinct class that hydrolyze lactams by a different mechanism
Metallo B-lactamases
Possess no antibacterial activity. They are combined with blactam antibiotics to extend their half-lives
B-lactamase inhibitors
These inhibitors bind b-lactamases covalently and inactivate irreversibly
Beta-lctamase inhibitors
Initially, b-lactamases were encoded by chromosomal genes of some bacteria. Amplification of the genes led to increased
Activity
Later, lactamases were found on plasmids that could transfer from
Organism to organism
Most active against plasmid encoded b-lactamases in staphylococci, H. influenza, N. gonorrhoeae, salmonella, shigella, E. coli, K. pneumoniae
Clavulanic Acid
Least active against chromosomally-encoded b-lactamases in enterobacter, citrobacter, serratia, pseudomonas
Clavulanic acid
Serine β-lactamases come in which three classes
A, C, and D
Traditional B-lactamase inhibitors work primarily on
Class A enzymes
A broader spectrum β-lactamases inhibitor that works on class A and C enzymes, as well as some D enzymes.
Avibactam
The inhibitor is coformulated with 3rd generation cephalosporin, ceftazidime
-Note: The inhibitor does not contain a β-lactam core
Avibactam
How many classes of penicillins are there, defined by core structure plus substituents
Common penicillins, anti-staphylococcal penicillins, and extended-spectrum penicillins
Acid labile. b-lactamase susceptible. Suitable for Gram(+), Gram(-) cocciand non blactamase-producing anaerobes
Common penicillins
Acid stable. b-lactamase resistant. Suitable for b-lactamase producing strains of staph, as well as penicillin-susceptible strains of streptococci and pneumonococci
Anti-staphylococcal penicillins
Not suitable for enterococci, anaerobic bacteria, and Gram(-) cocciand rods
Anti-staphylococcal penicillins
Acid stable. Greater activity against Gram(-) because of their ability to penetrate outer membrane. Suitable for UTIs, sinusitis, otitis, lower respiratory tract infections
Extended-spectrum penicillins
Extended-spectrum penicillins are inactivated by
Lactamases
Inactivated by lactamases. Thus, available in combination with b-lactamase inhibitors (eg. amoxicillin + clavulanate = Augmentin)
Extended-spectrum penicillins
Routes of administration-oral, IV and IM (if combined with anesthetic). When taken orally, ingest one hour before or after meal to avoid binding to food proteins
Penicillins
Penicillins are eliminated by
Rapid active secretion
80% of a dose of penicillin can be cleared in
3-4 hours after administration
Competitively inhibits penicillin secretion. Use it to increase steady state level and t1/2
Probenecid
Side effects can include diarrhea, nausea, rash, urticaria, and/or superinfectionwith other microbes (e.g. candidiasis)
Penicillins
If a patient is allergic to penicillin, we an substitute with
Cephalosporins
Penicillin resistance can occur by upregulation of chromosomally-encoded
B-lactamases
Penicillin resistance can also occur by acquisition of B-lactamaes by horizontal gene transfer from other
Bacteria
Mutation of the primary penicillin binding proteins (transpeptidases) such that penicillin binding affinity is reduced
MRSA
Broader spectrum due to increased resistance to b-lactamases
Cephalosporins
Not active against enterococci, L.monocytogenesor E. coliand Klebsiellastrains that express extended-spectrum b-lactamases
Cephalosporins
1st generation cephalosporins are broad spectrum, but are better for
Gram (+)
Restricted to surgical prophylaxis. Does not penetrate CNS
Cefazolin
In general they extend the coverage of Gram(-) bacteria over 1st generation drugs
-Heterogeneous class with individual specificities
2nd generation cephalosporins
Extend Gram(-) activity at the expense of Gram(+) activity
3rd generation cephalosporins
Some cross blood-brain barrier. Effective against inducible blactamase-production but not constitutive b-lactamase-producing strains
3rd generation cephalosporins
Cetftazidime+ β-lactamase inhibitor (avibactam)
Avycaz
More resistant to chromosomal b-lactamases
4th generation cephalosporins
Increased activity toward Gram(+) and Gram(-) species. True broad spectrum drug. Penetrates the CNS
4th generation cephalosporins
Route of administration -Some oral, some IV
Cephalosporins
Used for sinusitis, otitis and lower respiratory tract infections.
-Fourth generation appropriate for MRSA
Cephalosporins
Cephalosporins may elicit
Hypersensitivity reactions
A 5th generation cephalosporin for treatment of Gram(-) bacteria that have become resistant to other drugs, particularly pseudomonas infections
Ceftolozane
Used for complicated UTIs, and in combination to with metronidazole for complicated intra-abdominal infections
Ceftolozane
A β-lactamase inhibitor that extends half-life of the cephalosporin
Tazobactam
Approved in 2010 for use against MRSA.
-Drug has high affinity toward the unique transpeptidase commonly encoded by MRSA
Ceftaroline
Ceftaroline, like other later generation cephalosporins, works on both
Gram (+) and Gram (-) bacteria
The most common side effects of ceftaroline are
Diarrhea, nusea, and rash
Monocyclic core.
-Relatively resistant to b-lactamases
Monobactams
Monobactams are active against
Gram (-) rods
Monobactams have no activity against
Gram (+) rods
The drug does not bind transpeptidases of Gram(+) or anerobic bacteria
Monobactams
Broad spectrum antibiotics with good activity against many Gram(-) rods (including P aeruginosa), Gram(+) bacteria and anaerobes
Carbapenems
Resistant against the actions of serine b-lactamases but not metallo b-lactamases
Carbapenems
Inactivated by dehydropeptidases in renal tubules
Imipenem
An inhibitor of renal dehydropeptidase increases t1/2
Cilastatin
The carbapenems are well distributed, including penetration of CNS. All are cleared renally. Dose (by IV) must be adjusted in patients with
Renal insufficiency
Carbapenems may show cross-reactivity in patients with
Penicillin allergies
Glycopeptide isolated from soil bacterium.
-Active against Gram(+) bacteria, especially staphylococci
Vancomycin
Bactericidal for actively growing cells
-Binds the cell wall rather than enzymes used to make it
Vancomycin
Vancomycin binds tightly to D-Ala-D-Ala of nascent peptidoglycan pentapeptide. The binding interferes with
Transglycosylation and transpeptidation reactions
Vancomycin resistance in enterococci arises from a switch in the peptidoglycan pentapeptide from D-Ala-D-Ala to
D-Ala-D-Lac
Common indications: methicillin-resistant endocarditis or sepsis
Vancomycin
A better choice than vancomycin if the strain is methicillin sensitive
Penicillin
Routes of administration–usually IV, oral for enterocolitis and diarrhea caused by C. dificile
Vancomycin
Often used with aminoglycosides or gentamicin for treatment of enterococcal and other infections
Vancomycin
Semisynthetic lipoglycopeptide derivative of teicoplanin
-Effective for skin infections by MR gram-positive bacteria
Dalbavancin
Semisynthetic glycopeptide derived from vancomycin
-Comparable efficacy to vancomycin
Oritavancin
Cyclic lipopeptide isolated from soil bacteria
Daptomycin
Forms pores in membrane that allow K+ loss without cell rupture. No release of toxins
Daptomycin
Based on evolutionarily conserved antimicrobial host defense peptides mimetics.
-Thought to form pores, like daptomycin
Brilacidin
Brilacidin has potent broad-spectrum activity against Gram-positive and Gram-negative bacteria, including
MRSA
A class of lipopeptides that bind outer membrane of Gram(-) bacteria
Polymyxins
Polymyxins ultimately leads to the permeability of both the
Inner and outer membranes
Binds a lipopolysaccharide molecule specific to outer membranes of Gram(-) bacteria. There is little activity against Gram(+) bacteria
Polymyxins
Drug inhibits first committed step in cell wall synthesis: conversion of NAG-UDP to NAM-UDP
Fosfomycin
The drug binds covalently to the active site cysteine of the MurA enzyme
Fosfomycin
Naturally resistant to fosfomycin
MurA of TB
Fosfomycin is used for uncomplicated
UTIs
Cyclic polypeptide active against Gram(+) organisms
-Inhibits lipid phosphatase that dephosphorylates lipid carrier of peptidoglycan subunits
Bacitracin
Only used topically because too nephrotoxic
Bacitracin
Drug competitively inhibits alanine racemase and D-alanine ligase
D-cycloserine
Second line drug with serious side effects: Dose related CNS toxicity (headaches, tremors, convulsions, psychosis)
D-cycloserine